Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FK199B (Zolpidem MR) in Insomnia Associated with Schizophrenia and Bipolar Disorder
NCT00374777Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Aug 2006
- Primary completion
- May 2008
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of zolpidem sublingual tablet in Insomnia (4 arms), sponsored by Astellas Pharma. Primary endpoint: Mean wake time after sleep onset at 2 weeks. Started Aug 2006; status: completed.
02
Drugs
zolpidem sublingual tablet
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00374777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374777.